Logo image
Wnt/?-Catenin Signalling during Liver Metabolism, Chronic Liver Disease and Hepatocarcinogenesis
Journal article   Open access   Peer reviewed

Wnt/?-Catenin Signalling during Liver Metabolism, Chronic Liver Disease and Hepatocarcinogenesis

Gayatri D Shirolkar, Sara Pasic, Jully Gogoi Tiwari, Manoj K Bhat, John K Olynyk, Arun Dharmarajan and Janina EE Tirnitz-Parker
Journal of renal and hepatic disorders, Vol.2(1), pp.1-9
2018
pdf
Published5.64 MBDownloadView
CC BY V4.0 Open Access

Abstract

Chronic liver diseases (CLDs) are increasing in prevalence and their end-stage complications, namely, cirrhosis, liver failure and hepatocellular carcinoma represent major global challenges. The most common initiators of progressive CLD are viral hepatitis and long-term alcohol abuse as well as steatosis and steatohepatitis. Irrespective of the underlying aetiology, a common feature of CLD is the formation of hepatic ductular reactions, involving the proliferation of liver progenitor cells (LPCs) and their signalling to fibrosis-driving hepatic stellate cells. The Wnt/?-catenin pathway has been found to regulate development, stemness and differentiation, and alterations in its activity have been associated with tumour development. Recent data highlight the role of Wnt/?-catenin signalling in hepatic metabolism, steatosis and cancer, and suggest targeting of this pathway as a promising molecular strategy to potentially inhibit CLD progression and hepatocarcinogenesis.

Details

Metrics

32 File views/ downloads
9 Record Views
Logo image